HIKAL LIMITED (HIKAL) financials

HIKAL LIMITED (HIKAL) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.

Hikal is a partner to companies in the Pharmaceuticals, Crop Protection, and Specialty Chemicals industry. The company is in the business of supplying research services, active ingredients and intermediates for its customers. Hikal's manufacturing facilities have been inspected and approved by leading multinational companies in the Crop protection and Pharmaceutical sectors. The Crop protection f…

  • Market Cap: ₹2,679Cr.
  • Current Price: ₹217
  • Stock P/E: 62.7
  • ROE: 2.22%
  • ROCE: 3.51%
  • Book Value: ₹97.2
  • Dividend Yield: 0.28%
  • 52W High / Low: ₹261/146

In Jun 2026, HIKAL LIMITED (HIKAL) reported sales ₹402.80 Cr and net profit ₹-7.50 Cr.

Annual TTM: sales ₹1,735 Cr, net profit ₹-34 Cr.

Shareholding: Promoters 68.85% (Sep 2026), FIIs 1.28% (Sep 2026), DIIs 5.31% (Sep 2026), Public 24.57% (Sep 2026), No. of Shareholders 74,784% (Sep 2026).

HIKAL quarterly results (₹ Cr.)
CategorySep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales452.90447.70552.40380.40318.50494.30519.40402.80
Expenses378.20375.50428.90355.60311.10411.60413.80365.90
Operating Profit74.7072.20123.5024.807.4082.70105.6036.90
OPM %16.49%16.13%22.36%6.52%2.32%16.73%20.33%9.16%
Other Income0.403.600.501.001.90-35.20-40.5010.70
Interest18.8018.7017.9017.1014.9015.5014.6014.90
Depreciation31.7033.2037.7039.4041.2041.2042.0042.70
Profit before tax24.6023.9068.40-30.70-46.80-9.208.50-10.00
Tax %26.42%27.62%26.46%-26.06%-25.85%-35.87%-71.76%-25.00%
Net Profit18.1017.3050.30-22.70-34.70-5.9014.60-7.50
EPS in Rs1.471.404.08-1.84-2.81-0.481.18-0.61
Raw PDF————————
HIKAL profit and loss (₹ Cr.)
CategoryMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales1,5071,7201,9432,0231,7851,8601,7131,735
Expenses1,2341,3981,6021,7651,5181,5311,4921,502
Operating Profit273323341258267328220233
OPM %18%19%18%13%15%18%13%13%
Other Income-1255525-73-63
Interest5236314856756260
Depreciation828596109118134164167
Profit before tax12720621910595124-78-58
Tax %33%36%27%26%27%27%-38%—
Net Profit84133161787091-49-34
EPS in Rs6.8510.8013.026.365.647.37-3.95-2.72
Dividend Payout %18%19%12%19%21%19%-15%—
HIKAL balance sheet (₹ Cr.)
CategoryMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital2525252525252525
Reserves7327929091,0431,1091,1631,2381,174
Borrowings661646610675748818765684
Other Liabilities268306370470504482502483
Total Liabilities1,6861,7681,9132,2132,3852,4872,5292,365
Fixed Assets7137357138799481,0711,3641,333
CWIP7916125429541241412194
Investments11111551010
Other Assets8938719461,0281,0209971,034928
Total Assets1,6861,7681,9132,2132,3852,4872,5292,365
HIKAL cash flows (₹ Cr.)
CategoryMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity186285229294315187280302
Cash from Investing Activity-125-164-156-284-292-174-136-145
Cash from Financing Activity-55-101-97-6-8-27-144-160
Net Cash Flow620-24415-140-3
Free Cash Flow57127712113-17144154
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit73%113%85%107%134%81%94%144%
HIKAL shareholding pattern (%)
CategoryDec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Promoters68.85%68.85%68.85%68.85%68.85%68.85%68.85%68.85%
FIIs6.06%5.70%5.35%4.23%2.31%1.44%0.98%1.28%
DIIs3.48%3.80%4.03%5.15%7.05%7.20%7.23%5.31%
Public21.61%21.65%21.76%21.75%21.78%22.51%22.92%24.57%
No. of Shareholders71,80168,90771,39173,40474,11774,27073,52774,784
HIKAL key ratios
CategoryMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days8082103828011310394
Inventory Days156147107121104134146172
Days Payable68959291103123133128
Cash Conversion Cycle16813511811281124116138
Working Capital Days4528392639393741
ROCE %15%14%16%15%8%8%10%4%
HIKALUpdated 21 Oct 2026, 1:38

Hikal Limited

Market Cap

₹2,679Cr.

Current Price

₹217

High / Low

₹261/146

Stock P/E

62.7

ROE2.22%
ROCE3.51%
Book Value₹97.2
Face Value₹2.00
Dividend Yield0.28%

About

Hikal is a partner to companies in the Pharmaceuticals, Crop Protection, and Specialty Chemicals industry. The company is in the business of supplying research services, active ingredients and intermediates for its customers. Hikal's manufacturing facilities have been inspected and approved by leading multinational companies in the Crop protection and Pharmaceutical sectors. The Crop protection facilities are located at Taloja and Mahad {Maharashtra). The Pharmaceutical manufacturing facilities are situated in Jigani (Bengaluru) and Panoli (Gujarat). Hikal's R & D facilities are located in Pune.[1]

Quarterly results

Last reported quarters₹ Cr.

Profit & loss

Annual statement₹ Cr.

Shareholding pattern

As of Sep 2026%

Shareholding trend

Ownership over time%

Balance sheet

Assets & liabilities₹ Cr.

Cash flows

Operating, investing & financing₹ Cr.

Key ratios

Historical financial ratios
CategoryMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days544492818082103828011310394
Inventory Days268229189158156147107121104134146172
Days Payable117101938668959291103123133128
Cash Conversion Cycle20517318815316813511811281124116138
Working Capital Days-132943294528392639393741
ROCE %11%11%12%13%15%14%16%15%8%8%10%4%

Frequently asked questions

Quick answers about this company's financials on Fincrux

What is the market cap of HIKAL LIMITED (HIKAL)?

The reported market capitalisation for HIKAL LIMITED (HIKAL) is ₹2,679Cr. on Fincrux. Figures may update with market data and filings.

What is the current share price of HIKAL?

The current price shown for HIKAL LIMITED (HIKAL) on Fincrux is ₹217 with a 52-week high/low of ₹261/146.

What is the P/E ratio of HIKAL LIMITED (HIKAL)?

The stock P/E for HIKAL LIMITED (HIKAL) is 62.7 on Fincrux, with ROE at 2.22% and ROCE at 3.51%.

What were HIKAL latest quarterly results?

For Jun 2026, HIKAL LIMITED (HIKAL) reported sales ₹402.80 Cr and net profit ₹-7.50 Cr (figures in ₹ crore unless noted).

What are HIKAL annual sales and net profit?

For TTM, HIKAL LIMITED (HIKAL) shows sales of ₹1,735 Cr and net profit of ₹-34 Cr on the Fincrux profit & loss statement.

Who owns HIKAL LIMITED (HIKAL)?

Latest shareholding for HIKAL LIMITED (HIKAL) on Fincrux: Promoters 68.85% (Sep 2026), FIIs 1.28% (Sep 2026), DIIs 5.31% (Sep 2026), Public 24.57% (Sep 2026), No. of Shareholders 74,784% (Sep 2026).

Where can I find HIKAL LIMITED (HIKAL) financials?

HIKAL LIMITED (HIKAL) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.

Does Fincrux show HIKAL balance sheet and cash flow?

Yes. The HIKAL LIMITED (HIKAL) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 21 October 2026 at 1:38


Designed & Shipped by Harshit Bansal